SciELO - Scientific Electronic Library Online

 
vol.36 número2Mechanical properties of polycaprolactone microfilaments for muscular tissue engineeringAnálisis de la situación actual de residuos marinos en Costa Rica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Tecnología en Marcha

versión On-line ISSN 0379-3982versión impresa ISSN 0379-3982

Resumen

CAMACHO-SANCHEZ, Melissa et al. Biomarcadores en el diagnóstico temprano y tratamiento de cáncer. Tecnología en Marcha [online]. 2023, vol.36, n.2, pp.109-117. ISSN 0379-3982.  http://dx.doi.org/10.18845/tm.v36i2.6002.

In this paper points up the importance of biomarkers in the biomedical area for the development of technologies that allow early diagnosis and treatment of diseases such as cancer. Three of the biomarkers for cancer that have been shown to be effective for its treatment are highlighted: the prostate specific antigen (PSA), which is of utmost importance when determining recurrences of prostate cancer and evaluating the response to treatment, micro RNA (miRNA), which is altered in cancer cells, and the hormone β-HCG. The latter can be used as a tumor marker for various types of cancer and it has been determined that this hormone can act as an inhibitor of apoptosis and stimulate the growth of cellular cancers. Furthermore, there is a direct relationship between the concentration of β-HCG and the aggressiveness of the cancer.

Palabras clave : Prostate specific antigen; miRNA; β-HCG hormone; preclinical tests; prostate cancer.

        · resumen en Español     · texto en Español     · Español ( pdf )